Cargando…
Phage therapy for severe bacterial infections: a narrative review
Bacteriophage (phage) therapy is re‐emerging a century after it began. Activity against antibiotic‐resistant pathogens and a lack of serious side effects make phage therapy an attractive treatment option in refractory bacterial infections. Phages are highly specific for their bacterial targets, but...
Autores principales: | Petrovic Fabijan, Aleksandra, Khalid, Ali, Maddocks, Susan, Ho, Josephine, Gilbey, Timothy, Sandaradura, Indy, Lin, Ruby CY, Ben Zakour, Nouri, Venturini, Carola, Bowring, Bethany, Iredell, Jonathan R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9545287/ https://www.ncbi.nlm.nih.gov/pubmed/31587298 http://dx.doi.org/10.5694/mja2.50355 |
Ejemplares similares
-
Adjunctive bacteriophage therapy for prosthetic valve endocarditis due to Staphylococcus aureus
por: Gilbey, Timothy, et al.
Publicado: (2019) -
Biological foundations of successful bacteriophage therapy
por: Venturini, Carola, et al.
Publicado: (2022) -
Translating phage therapy into the clinic: Recent accomplishments but continuing challenges
por: Petrovic Fabijan, Aleksandra, et al.
Publicado: (2023) -
Diversity of P1 phage-like elements in multidrug resistant Escherichia coli
por: Venturini, Carola, et al.
Publicado: (2019) -
Co-Occurrence of Multidrug Resistant Klebsiella pneumoniae Pathogenic Clones of Human Relevance in an Equine Pneumonia Case
por: Venturini, Carola, et al.
Publicado: (2022)